A massive valuation for a "seed" round can be misleading. Often, insiders have participated in several unannounced, cheaper tranches. The headline number is just the final, most expensive tier, used to create FOMO and set a high watermark for new investors.

VCs may invest in two tranches at different valuations (e.g., $500M and $1B) but allow the founder to publicize only the higher number. This practice can make the company seem more valuable than its blended price, potentially misleading employees and future investors.

The first question in any fundraising or M&A discussion is always, 'What was your last round price?' An inflated number creates psychological friction and can halt negotiations before they begin. Founders should optimize for a valuation that allows for a clear up-round, not just the highest price today.

Accepting too high a valuation can be a fatal error. The first question in any subsequent fundraising or M&A discussion will be about the prior round's price. An unjustifiably high number immediately destroys the psychology of the new deal, making it nearly impossible to raise more capital or sell the company, regardless of progress.

Valuations don't jump dramatically; they 'sneak up on you.' An investor might balk at a $45M cap when they expected $40M. But the fear of missing a potential unicorn is stronger than the desire for a slightly better price, causing a gradual, batch-over-batch inflation of valuation norms.

A sharply increasing valuation isn't a sign of overpricing; it's often a sign of underpricing. Investors anchor to previous rounds instead of the company's current reality and future potential, causing even a 2x up-round to be less than the 4x it might deserve.

Sequoia sometimes invests in two tranches at different valuations. This allows founders to market the round at the higher valuation, while Sequoia benefits from a lower, blended price. This practice, while common, can mislead employees and other investors about the true deal terms if not properly disclosed.

Tranched rounds involve an investor buying shares at two prices (e.g., $250M and $1B) in the same financing. While the investor gets a lower blended cost basis, the company gets to announce the higher valuation. It's a financial engineering tactic that satisfies egos but creates an optics trap.

Seed funds can win deals against multistage giants by highlighting the inherent conflict of interest. A seed-only investor is fully aligned with the founder to maximize the Series A valuation, whereas a multistage investor may want a lower price for their own follow-on investment.